Who is sponsoring NCT04951973?

NCT04951973 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT04951973?

Interventions in NCT04951973: Deep Learning Based Early Warning Score (DEWS).

What condition does NCT04951973 study?

NCT04951973 studies Hospital Rapid Response Team, Hospital Medical Emergency Team.

Is NCT04951973 still recruiting?

NCT04951973 is currently status unknown. Last updated 7 July 2021.

Last reviewed 2021-07-07 · How we verify

NCT04951973

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Deep Learning Based Early Warning Score in Rapid Response Team Activation

Status unknown Last updated 7 July 2021

What this trial tests

trial testing Deep Learning Based Early Warning Score (DEWS) in Hospital Rapid Response Team in 50,000 participants. Status unknown.

Timeline

1 August 2021

Primary endpoint
30 December 2021

30 April 2022

Quick facts

Lead sponsor	Seoul National University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50,000
Start date	1 August 2021
Primary completion	30 December 2021
Estimated completion	30 April 2022

Drugs / interventions tested

Deep Learning Based Early Warning Score (DEWS)

Conditions studied

Hospital Rapid Response Team — all drugs for Hospital Rapid Response Team →
Hospital Medical Emergency Team — all drugs for Hospital Medical Emergency Team →

Sponsor

Seoul National University Hospital

Who can join

18 and older, any sex, with Hospital Rapid Response Team or Hospital Medical Emergency Team. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate the safety and clinical usefulness of the Deep learning based Early Warning Score (DEWS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prospective, multicenter validation of the deep learning-based cardiac arrest risk management system for predicting in-hospital cardiac arrest or unplanned intensive care unit transfer in patients admitted to general wards.
Cho KJ, Kim JS, Lee DH, Lee SM, et al · · 2023 · cited 20× · PMID 37670324 · DOI 10.1186/s13054-023-04609-0

Verify or expand the search:

Other recruiting trials for Hospital Rapid Response Team

Currently open trials in the same condition.

NCT04507737 — Rapid Response Teams - How and Who? · NA · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04951973 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 7 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04951973.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing